Staphylococcus aureus adhesion via Spa, ClfA, and SdrCDE to immobilized platelets demonstrates shear-dependent behavior

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 26, Issue 10, 2006, Pages 2394-2400

  George, Niraj Procopio Evagrio ^a   Wei, Qi ^a   Shin, Pyong Kyun ^a   Konstantopoulos, Konstantinos ^b   Ross, Julia M ^a,c  

^a UNIVERSITY OF MARYLAND BALTIMORE COUNTY   (United States)

^b Johns Hopkins University   (United States)

^c University of Marylandw Baltimore County   (United States)

Author keywords

Clumping factor A; Fibrinogen; Protein A; Serine aspartate repeats; Staphylococcus aureus; Von Willebrand factor

Indexed keywords

ADHESIN; FIBRINOGEN; PROTEIN CLFA; PROTEIN SDRC; PROTEIN SDRD; PROTEIN SDRE; PROTEIN SPA; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR;

ANIMAL CELL; ARTICLE; BACTERIAL STRAIN; BACTERIUM ADHERENCE; CELL FUNCTION; CELL INTERACTION; CONTROLLED STUDY; IMMOBILIZED CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SHEAR STRESS; STAPHYLOCOCCUS AUREUS; THROMBOCYTE; WILD TYPE;

ADHESINS, BACTERIAL; ALANINE; BACTERIAL ADHESION; BLOOD PLATELETS; BLOOD PROTEINS; FIBRINOGEN; HUMANS; OLIGOPEPTIDES; OXAZOLES; PLATELET ADHESIVENESS; PLATELET AGGREGATION INHIBITORS; STAPHYLOCOCCUS AUREUS; STRESS, MECHANICAL; VON WILLEBRAND FACTOR;

EID: 33749054710     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000237606.90253.94     Document Type: Article

References (41)

1. Mascari L, Ymele-Leki P, Eggleton CD, Speziale P, Ross JM. Fluid shear contributions to bacteria cell detachment initiated by a monoclonal antibody. Biotechnol Bioeng. 2003;83:65-74.
2. Brouillette E, Lacasse P, Shkreta L, Belanger J, Grondin G, Diarra MS, Fournier S, Talbot BG. DNA immunization against the clumping factor A (ClfA) of Staphylococcus aureus. Vaccine. 2002;20:2348-2357.
3. Cordwell SJ, Larsen MR, Cole RT, Walsh BJ. Comparative proteomics of Staphylococcus aureus and the response of methicillin-resistive strains to triton X-100. Microbiology. 2002;148:2765-2781.
4. Reduced susceptibility of Staphylococcus aureus to vancomycin - Japan, 1996. MMWR. 1997;46:624-626.
5. Prevention CfDCa. Vancomycin - Intermediate/Resistant Staphylococcus aureus. Fact sheet. 2003.
6. Gilaspy A, Lee C, Sau S, Cheung A, Smeltzer M. Factors affecting the collagen binding capacity of Staphylococcus aureus. Infect Immun. 1998;66:3170-3178.
7. Patti JM, Allen BL, McGavin MJ, Hook M. MSCRAMM-mediated adherence of microorganisms to host tissues. Annu Rev Microbiol. 1994;48:585-617.
8. Heilmann C, Herrmann M, Kehrel BE, Peters G. Platelet-binding domains in 2 fibrinogen-binding proteins of Staphylococcus aureus identified by phage display. J Infect Dis. 2002;186:32-39.
9. Moreillon P, Entenza J, Francioli P, McDevitt D, Foster T, Francois P, Vaudaux P. Role of Staphylococcus aureus coagulase and clumping factor in pathogenesis of experimental endocarditis. Infect Immun. 1995;63:4738-4743.
10. Hartford OM, Wann ER, Hook M, Foster TJ. Identification of residues in the Staphylococcus aureus fibrinogen-binding MSCRAMM clumping factor A (ClfA) that are important for ligand binding. J Biol Chem. 2001;276:2466-2473.
11. Siboo IR, Cheung AL, Bayer AS, Sullam PM. Clumping factor A mediates binding of Staphylococcus aureus to human platelets. Infect Immun. 2001;69:3120-3127.
12. Pawar P, Shin PK, Mousa SA, Ross JM, Konstantopoulos K. Fluid shear regulates the kinetics and receptor specificity of Staphylococcus aureus binding to activated platelets. J Immunol. 2004;173:1258-1265.
13. Loughman A, Fitzgerald JR, Brennan MP, Higgins J, Downer R, Cox D, Foster TJ. Roles for fibrinogen, immunoglobulin and complement in platelet activation promoted by Staphylococcus aureus clumping factor A. Mol Microbiol. 2005;57:804-818.
14. Hartleib J, Kohler N, Dickinson RB, Chhatwal GS, Sixma JJ, Hartford OM, Foster TJ, Peters G, Kehrel BE, Herrmann M. Protein A is the von Willebrand factor binding protein on Staphylococcus aureus. Blood. 2000;96:2149-2156.
15. Josefsson E, McCrea KW, Eidhin DN, O'Connell D, Cox J, Hook M, Foster TJ. Three new members of the serine-aspartate repeat protein multigene family of Staphylococcus aureus. Microbiology. 1998;144:3387-3395.
16. Josefsson E, O'Connell D, Foster TJ, Durussel I, Cox J. The binding of calcium to the B-repeat segment of SdrD, a cell surface protein of Staphylococcus aureus. J Biol Chem. 1998;273:31145-31152.
17. Konstantopoulos K, Kukreti S, McIntire LV. Biomechanics of cell interactions in shear fields. Adv Drug Delivery Rev. 1998;33:141-164.
18. Weiss HJ, Turitto VT, Baumgartner HR. Role of shear rate and platelets in promoting fibrin formation on rabbit subendothelium. J Clin Invest. 1986;78:1072-1082.
19. Goto S, Ikeda K, Saldivar E, Ruggeri ZM. Distinct mecahnisms of platelet aggregation as a consequence of different shearing flow conditions. J Clin Invest. 1998;101:479-486.
20. Ruggeri ZM. Structure and function of von Willebrand factor. Thromb Haemost. 1999;82:576-584.
21. Ikeda Y, Handa M, Kawano K, Kamata T, Murata M, Araki Y, Anbo H, Kawai Y, Watanabe K, Itagaki I. The role of von Willebrand factor and fibrinogen in platelet aggregation under varying shear stress. J Clin Invest. 1991;87:1234-1240.
22. Mascari L, Ross JM. Hydrodynamic shear and collagen receptor density determine the adhesion capacity of S. aureus to collagen. Ann Biomed Eng. 2001;29:956-962.
23. Abulencia JP, Tien N, McCarty OJ, Plymire D, Mousa SA, Konstantopoulos K. Comparative antiplatelet efficacy of a novel, nonpeptide GPIIb/IIIa antagonist (XV454) and Abciximab (c7E3) in flow models of thrombosis. Arterioscler Thromb Vasc Biol. 2001;21:149-156.
24. O'Brien L, Kerrigan SW, Kaw G, Hogan M, Penadés J, Litt D, Fitzgerald DJ, Foster TJ, Cox D. Multiple mechanisms for the activation of human platelet aggregation by Staphylococcus aureus: roles for the clumping factors ClfA and ClfB, the serine-aspartate repeat protein SdrE and protein A. Mol Microbiol. 2002;44:1033-1044.
25. McCarty OJT, Tien N, Bochner BS, Konstantopoulos K. Exogenous eosinophil activation converts PSGL-1-dependent binding to CD18-dependent stable adhesion to platelets in shear flow. Am J Cell Physiol. 2003;284:C1223-C1234.
26. Gartner TK, Bennett JS. The tetrapeptide analogue of the cell attachment site of fibronectin inhibits platelet aggregation and fibrinogen binding to activated platelets. J Biol Chem. 1985;260:11891-11894.
27. Steinberg JP, Clark CC, Hackman BO. Nosocomial and community-acquired Staphylococcus aureus bacteremias from 1980 to 1993: impact of intravascular devices and methicillin resistance. Clin Infect Dis. 1996;23:255-259.
28. Yanagihara C, Wada Y, Nishimura Y. Infectious endocarditis associated with subarachnoid hemorrhage, subdural hematoma and multiple brain abscesses. Intern Med. 2003;42:1244-1247.
29. Yeaman MR, Bayer AS. Staphylococcus aureus, platelets, and the heart. Curr Infect Dis Rep. 2000;2:281-298.
30. Bayer AS, Sullam PM, Ramos M, Li C, Cheung AL, Yeaman MR. Staphylococcus aureus induces platelet aggregation via a fibrinogen-dependent mechanism which is independent of principal platelet glycoprotein IIb/IIIa fibrinogen-binding domains. Infect Immun. 1995;63:3634-3641.
31. Turrito VT, Goldsmith HL. Rheological aspects of thrombosis and hemostasis: basic principles and applications. Thromb Haemost. 1986;55:415-435.
32. Hall AE, Domanski PJ, Patel PR, Vernachio JH, Syribeys PJ, Gorovits EL, Johnson MA, Ross JM, Hutchins JT, Patti JM. Characterization of a Protective Monoclonal Antibody Recognizing Staphylococcus aureus MSCRAMM Protein Clumping Factor A. Infect Immun. 2003;71:6864-6870.
33. Bonnefoy A, Liu Q, Legrand C, Frojmovic MM. Efficiency of platelet adhesion to fibrinogen depends on both cell activation and flow. Biophys J. 2000;78:2834-2843.
34. Tsuji S, Sugimoto M, Miyata S, Kuwahara M, Kinoshita S, Yoshioka A. Real-time analysis of mural thrombus formation in various platelet aggregation disorders: Distinct shear-dependant roles of platelet receptors and adhesive proteins under flow. Blood. 1999;94:968-975.
35. Siedlecki CA, Lestini BJ, Kottke-Marchant KK, Eppell SJ, Wilson DL, Marchant RE. Shear-dependent changes in the three-dimensional structure of human von Willebrand factor. Blood. 1996;88:2939-2950.
36. Sugimoto M, Miyata S. Functional property of von Willebrand factor under flowing blood. Int J Hematol. 2002;75:19-24.
37. Miura S, Sakurai Y, Takatsuka H, Yoshioka A, Matsumoto M, Yagi H, Kokubo T, Ikeda Y, Matsui T, Titani K, Fujimura Y. Total inhibition of high shear stress induced platelet aggregation by homodimeric von Willebrand factor A1-loop fragments. Br J Haematol. 1999;105:1092-1100.
38. Cruz MA, Yuan H, Lee JR, Wise RJ, Handin RI. Interaction of the von Willebrand factor (vWF) with collagen. J Biol Chem. 1995;270:10822-10827.
39. Nguyen T, Ghebrehiwet B, Peerschke EIB. Staphylococcus aureus Protein A Recognizes Platelet gC1qR/p33: a Novel Mechanism for Staphylococcal Interactions with Platelets. Infect Immun. 2000;68:2061-2068.
40. Lawrence JB, Kramer WS, McKeown LP, Williams SB, Grainick HR. Arginine-glycine-aspartic acid and fibrinogen γ-chain carboxy terminal peptides inhibit platelet adherence to arterial subendothelium at high wall shear rates. An effect dissociable from interference with adhesive protein binding. J Clin Invest. 1990;86:1715-1722.
41. Matsui H, Sugimoto M, Mizuno T, Tsuji S, Miyata S, Matsuda M, Yoshioka A. Distinct and concerted functions of von Willebrand factor and fibrinogen in mural thrombus growth under high shear flow. Blood. 2002;100:3604-3610.